Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Julphar
Healthtrust
UBS
Cantor Fitzgerald
Fuji
QuintilesIMS
AstraZeneca
Fish and Richardson

Generated: October 22, 2018

DrugPatentWatch Database Preview

Ribavirin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ribavirin and what is the scope of ribavirin patent protection?

Ribavirin is the generic ingredient in six branded drugs marketed by Merck Sharp Dohme, Kadmon Pharms Llc, Aurobindo Pharma, Casi Pharms Inc, Teva, Zydus Pharms Usa, Navinta Llc, Valeant Pharm Intl, Schering, Roche, Sandoz, and Sandoz Inc, and is included in sixteen NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for ribavirin. Thirteen suppliers are listed for this compound. There is one tentative approval for this compound.

Pharmacology for ribavirin
Medical Subject Heading (MeSH) Categories for ribavirin
Synonyms for ribavirin
1-?-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide
1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-1,2,4-triazole-3-carboxamide
1-(beta -D-ribofuranosyl)-1,2,4-triazole-3-carboxamide
1-(beta-D-Ribofuranosyl)-1,2,4-triazole-3-carboxamide
1-(beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide
1-|A-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
1-beta-Ribofuranosyl-1,2,4-triazole-3-carboamide
1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl-
1H-1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl-
252269-50-4
36791-04-5
437710-49-1
49717AWG6K
4pb1
66510-90-5
791R045
AA-504/07617051
AB00430481
AB00430481_17
AB00430481_18
AB00430481-15
AB00430481-16
AB0068936
AC1L1XXZ
AC1Q1IDC
AC1Q4ZGS
AJ-24715
AK-49185
AKOS001715163
API0004062
AX8005387
BB_NC-00567
BB_NC-0567
BCP0726000138
BDBM50154375
BIB6306
BPBio1_001195
BR-49185
BRD-K60369935-001-02-7
BRN 0892462
BSPBio_001085
BSPBio_003352
C-14783
C-Virin
CAS-36791-04-5
CC-34249
CCG-38985
CHEBI:63580
CHEMBL1643
cid_37542
Copegus
Copegus (TN)
Cotronak
CPD000058315
CS-2540
CTK7J7594
D00423
D0DI8X
D0H3WI
DB00811
DivK1c_000782
DR000602
DRG-0028
Drug: Ribavirin
Drug: Ribavirin
DSSTox_CID_3557
DSSTox_GSID_23557
DSSTox_RID_77081
DTXSID8023557
EN300-59237
EU-0101063
FT-0082885
FT-0630597
FT-0649908
GS-3572
GTPL6842
HMS2090L15
HMS2094O09
HMS2098G07
HMS2232P07
HMS3263E08
HMS502H04
HSDB 6513
HY-B0434
ICN-1229
IDI1_000782
IWUCXVSUMQZMFG-AFCXAGJDSA-N
J10190
KBio1_000782
KBio2_002328
KBio2_004896
KBio2_007464
KBio3_002854
KBioGR_001804
KBioSS_002331
KS-1104
Lopac0_001063
LP01063
LS-1241
M-7546
MCULE-9495128592
MFCD00058564
MLS000028486
MLS002222317
MolPort-002-507-104
NCGC00015904-02
NCGC00090726-01
NCGC00090726-03
NCGC00090726-04
NCGC00090726-05
NCGC00090726-06
NCGC00090726-07
NCGC00090726-08
NCGC00090726-09
NCGC00090726-12
NCGC00258520-01
NCGC00261748-01
NINDS_000782
NSC 163039
NSC-758650
NSC163039
NSC758650
NU000208
NU001372
NU007464
Pharmakon1600-01503938
Prestwick3_000993
PubChem14187
R 9644
R-964
R0077
Ravanex
RBI034 (2-5A antisense compound) + Ribavirin
RBV
Rebetol
Rebetol (TN)
Rebetron
Rebretron
RG-964
Ribacine
Ribamide
Ribamidil
Ribamidyl
Ribasphere
Ribasphere (TN)
Ribav
Ribavarin
Ribavirin (Copegus)
Ribavirin (JAN/USP/INN)
Ribavirin (JP17/USP/INN)
Ribavirin [USAN:INN]
Ribavirin Capsules
Ribavirin, antiviral
Ribavirin, British Pharmacopoeia (BP) Reference Standard
Ribavirin, European Pharmacopoeia (EP) Reference Standard
Ribavirin, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Ribavirin, United States Pharmacopeia (USP) Reference Standard
Ribavirina
Ribavirina [INN-Spanish]
Ribavirine
Ribavirine [INN-French]
Ribavirine;
Ribavirinum
Ribavirinum [INN-Latin]
ribofluranosyl carboxamide
Ribovirin
Ro 20-9963/000
Ro-20-9963
RTC
RTCA
s2504
SAM002548967
SBI-0051033.P003
SC-12159
SCH 18908
SCHEMBL3727
SMP1_000261
SMR000058315
Spectrum_001826
SPECTRUM1503938
Spectrum3_001876
Spectrum4_001252
Spectrum5_002075
SR-01000076112-3
SR-01000721904
SR-01000721904-2
ST2413783
Tox21_110259
Tox21_110259_1
Tox21_200967
Tox21_501063
Tribavirin
UNII-49717AWG6K
Varazid
Vilona
Vilona (TN)
Viramid
Viramide
Virazid
Virazide
Virazole
Virazole (Ribavirin) Inhalation Solution
Virazole (TN)
Z1522567185
ZB015662
ZINC1035331
Tentative approvals for RIBAVIRIN
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free Trial40MG/MLSOLUTION; ORAL

US Patents and Regulatory Information for ribavirin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa RIBAVIRIN ribavirin TABLET;ORAL 077094-004 Apr 18, 2008 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharm Intl VIRAZOLE ribavirin FOR SOLUTION;INHALATION 018859-001 Dec 31, 1985 AN RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Kadmon Pharms Llc RIBASPHERE ribavirin CAPSULE;ORAL 076203-001 Apr 6, 2004 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Kadmon Pharms Llc RIBAVIRIN ribavirin TABLET;ORAL 077456-003 Dec 5, 2005 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Navinta Llc RIBAVIRIN ribavirin FOR SOLUTION;INHALATION 207366-001 Oct 6, 2016 AN RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva RIBAVIRIN ribavirin TABLET;ORAL 077053-001 Dec 5, 2005 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz Inc RIBAVIRIN ribavirin TABLET;ORAL 202546-002 Aug 12, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for ribavirin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme REBETOL ribavirin CAPSULE;ORAL 020903-002 Jul 25, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme REBETOL ribavirin CAPSULE;ORAL 020903-002 Jul 25, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharm Intl VIRAZOLE ribavirin FOR SOLUTION;INHALATION 018859-001 Dec 31, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme REBETOL ribavirin CAPSULE;ORAL 020903-001 Jun 3, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharm Intl VIRAZOLE ribavirin FOR SOLUTION;INHALATION 018859-001 Dec 31, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme REBETOL ribavirin CAPSULE;ORAL 020903-002 Jul 25, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme REBETOL ribavirin CAPSULE;ORAL 020903-001 Jun 3, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Julphar
Healthtrust
UBS
Cantor Fitzgerald
Fuji
QuintilesIMS
AstraZeneca
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.